XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Cash Flows from Operating Activities      
Net Loss from Operations $ (7,930,453) $ (9,804,748)  
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:      
Depreciation 13,580 7,873  
Amortization of Right-Of-Use Asset 157,068 81,013  
Amortization of Debt Discount 450,000 553,961  
Shared-based Compensation & Expense 134,192  
Foreign Exchange Transaction Gain (408,630) (1,462,697)  
Unrealized Loss on Securities Investment 3,899,015 9,548,251  
Realized Loss on Securities Investment 3,436,783  
Loss on Equity Method Investment 133,983 24,847  
Changes in Operating Assets and Liabilities      
Real Estate (336,426) 441,764  
Account Receivables 19,416 203,816  
Prepaid Expense 679,069 (1,458,620)  
Trading Securities 4,068,011 (2,452,754)  
Inventory 10,902 77,709  
Accounts Payable and Accrued Expenses (8,792,327) 596,355  
Accrued Interest - Related Parties 41,239  
Deferred Revenue (508,328) 563,667  
Operating Lease Liability (153,692) (66,954)  
Builder Deposits (31,553) (333,771)  
Net Cash Used in Operating Activities (5,293,582) (3,304,857)  
Cash Flows from Investing Activities      
Purchase of Fixed Assets (3,665) (3,767)  
Purchase of Real Estate Properties (722,817)  
Purchase of Investment Securities (6,585,294) (108,208)  
Sales of Investment Securities to Related Party 2,480,000  
Promissory Note to Related Party (15,489)  
Net Cash (Used in) Provided by Investing Activities (7,311,776) 2,352,536  
Cash Flows from Financing Activities      
Conversion of Related Party Note to Common Stock 6,213,000  
Proceeds from Exercise of Subsidiary Warrants 7,484  
Proceeds from Sale of Subsidiary Shares 250,000  
Borrowing from PPP Loan 68,502  
Distribution to Non-controlling Interest Shareholders (82,250)  
Repayment to Notes Payable (168,360)  
Repayment to Notes Payable - Related Parties (1,200,000)  
Net Cash Provided by (Used in) Financing Activities 6,044,640 (956,264)  
Net Decrease in Cash and Restricted Cash (6,560,718) (1,908,585)  
Effects of Foreign Exchange Rates on Cash (195,308) (31,788)  
Cash and Restricted Cash - Beginning of Year 60,802,179 31,235,456 $ 31,235,456
Cash and Restricted Cash- End of Period 54,046,153 29,295,083 $ 60,802,179
Supplementary Cash Flow Information      
Cash Paid for Interest 1,524 6,627  
Cash Paid for Taxes 45,410  
Supplemental Disclosure of Non-Cash Investing and Financing Activities      
Unrealized Gain (Loss) on Investment 728,449 (1,987)  
Initial Recognition of ROU / Lease Liability 256,928  
Acquiring True Partner Stock 10,003,689  
Sale of Investment in Vivacitas to Related Party 2,279,872  
Deconsolidate Alset Capital Acquisition 19,388,544  
Intrinsic Value of BCF 450,000  
Issuance of Stock by Exercising Warrants 3,895  
Transactions under Common Control $ 57,190,499